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Pnspiratory Muscle Training in Patients With
eart Failure and Inspiratory Muscle Weakness
Randomized Trial
edro Dall’Ago, PT, SCD,*† Gaspar R. S. Chiappa, PT, MSC,‡ Henrique Guths, PT, MSC,†
icardo Stein, MD, SCD,‡ Jorge P. Ribeiro, MD, SCD‡§
orto Alegre and Canoas, Brazil
OBJECTIVES This study sought to evaluate the effects of inspiratory muscle training in inspiratory muscle
strength, as well as in functional capacity, ventilatory responses to exercise, recovery oxygen
uptake kinetics, and quality of life in patients with chronic heart failure (CHF) and inspiratory
muscle weakness.
BACKGROUND Patients with CHF may have reduced strength and endurance in inspiratory muscles, which
may contribute to exercise intolerance and is associated with a poor prognosis.
METHODS Thirty-two patients with CHF and weakness of inspiratory muscles (maximal inspiratory
pressure [PImax] 70% of predicted) were randomly assigned to a 12-week program of
inspiratory muscle training (IMT, 16 patients) or to a placebo-inspiratory muscle training
(P-IMT, 16 patients). The following measures were obtained before and after the program:
PImax at rest and 10 min after maximal exercise; peak oxygen uptake, circulatory power,
ventilatory oscillations, and oxygen kinetics during early recovery (V˙O2/tslope); 6-min walk
test; and quality of life scores.
RESULTS The IMT resulted in a 115% increment PImax, 17% increase in peak oxygen uptake, and 19%
increase in the 6-min walk distance. Likewise, circulatory power increased and ventilatory
oscillations were reduced. The V˙O2/tslope was improved during the recovery period, and
quality of life scores improved.
CONCLUSIONS In patients with CHF and inspiratory muscle weakness, IMT results in marked improvement
in inspiratory muscle strength, as well as improvement in functional capacity, ventilatory
response to exercise, recovery oxygen uptake kinetics, and quality of life. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.0522006;47:757–63) © 2006 by the American College of Cardiology Foundation
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cost patients with chronic heart failure (CHF) are limited
n their physical activity by fatigue and dyspnea, and it has
een suggested that respiratory muscle weakness and decon-
itioning may be involved in the increased work of breath-
ng during hyperpnea (1). Some of these patients show
educed maximal inspiratory pressure (PImax) and endurance
f inspiratory muscles, which are currently recognized as
dditional factors implicated in the limited exercise response
nd quality of life, as well as in their poor prognosis (2).
bnormal ventilatory response to exercise (3), periodic
reathing (4), and delayed oxygen uptake kinetics during
ecovery of maximal effort (5) have also been associated with
everity of and poor prognosis in CHF. The precise cause of
his respiratory muscle dysfunction remains speculative, but
iaphragm biopsies have shown a variety of histological
bnormalities in CHF, including fiber type I atrophy (6),
hich have been implicated in a generalized skeletal muscle
isorder in CHF (7).
Few studies have evaluated the effects of inspiratory
uscle training in patients with CHF, and their results are
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iências Médicas de Porto Alegre, Porto Alegre, Brazil; †School of Physical Therapy,
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orto Alegre, Porto Alegre, Brazil; and the §Department of Medicine, Faculty of
edicine, UFRGS, Porto Alegre, Brazil. Supported by grants from: CAPES and
NPq, Brasília, Brazil, and FIPE-HCPA, Porto Alegre, Brazil.c
Manuscript received May 24, 2005; revised manuscript received August 21, 2005,
ccepted September 26, 2005.ontradictory (8–11). Nonrandomized trials (8,11) have
hown improvement in maximal functional capacity after
nspiratory muscle training, but these beneficial effects have
ot been confirmed by randomized studies (9,10). More-
ver, the effects of inspiratory muscle training on several
arkers of prognosis obtained from cardiopulmonary exer-
ise testing (CPET) have not been previously reported.
herefore, we conducted this randomized trial to test the
ypothesis that a 12-week program of inspiratory muscle
raining could be associated with improvement in functional
apacity, circulatory power, oscillatory ventilation, kinetics
f oxygen consumption in the recovery period, and quality
f life in patients with CHF and inspiratory muscle
eakness.
ETHODS
atients and design. A prospective, randomized, controlled
rial was conducted in patients with the diagnosis of CHF
ttributable to left ventricular systolic dysfunction (left
entricular ejection fraction 45%) who were recruited
rom the Heart Failure Clinic at the Hospital de Clínicas de
orto Alegre. Entry criteria for the study were a previous
istory of symptomatic heart failure caused by left ventric-
lar systolic dysfunction, inspiratory muscle weakness (PImax
70% of the predicted), and clinical stability, including no
hange in medications for the past three months. Exclusion
riteria were unstable angina, myocardial infarction, or cardiac
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olic, orthopedic, or infectious disease; treatment with
teroids, hormones, or cancer chemotherapy. Patients with
revious pulmonary disease (forced vital capacity 80% of
redicted and/or forced expiratory volume in 1 s 70% of
redicted) (12), history of exercise-induced asthma, and
mokers were not recruited. The protocol was approved by
he Committee for Ethics in Research of the Hospital de
línicas de Porto Alegre, and all subjects signed an in-
ormed consent form.
Eligible patients were initially evaluated by medical
istory, physical examination, resting electrocardiogram,
wo-dimensional echocardiogram, pulmonary function, and
nspiratory muscle function. Patients were randomly as-
igned to inspiratory muscle training (IMT) or to placebo-
nspiratory muscle training (P-IMT) for 12 weeks. Before
nd after the intervention, pulmonary function tests, in-
piratory muscle function tests, cardiopulmonary exercise
esting (CPET), 6-min walk test, and quality of life assess-
ent were obtained. After finishing the intervention, none
f the patients continued with inspiratory muscle training or
ith any formal exercise program. One year after entering the
tudy, 11 patients in each group were re-evaluated for inspira-
ory muscle strength and quality of life. All evaluations were
erformed by investigators who were unaware of the allocation
f patients to different interventions.
nspiratory muscle training. Patients received either IMT
r P-IMT for 30 min 7 times per week, for 12 weeks using
he Threshold Inspiratory Muscle Training device (Thresh-
ld Inspiratory Muscle Trainer, Healthscan Products Inc.,
edar Grove, New Jersey). During training, patients were
nstructed to maintain diaphragmatic breathing, with a
reathing rate at 15 to 20 breaths/min. For the IMT group,
nspiratory load was set at 30% of maximal static inspiratory
ressure, and weekly training loads were adjusted to main-
ain 30% of the PImax. The P-IMT followed the same
Abbreviations and Acronyms
  relative amplitude of oscillations
CHF  chronic heart failure
CPET  cardiopulmonary exercise testing
IMT  inspiratory muscle training
P-IMT  placebo inspiratory muscle training
PImax  maximal static inspiratory pressure
Pthmax  maximal inspiratory pressure sustained
for 1 min during incremental test
R  respiratory exchange ratio
/t slope  kinetics during recovery
T1/2  time required for 50% from peak
V˙CO2  carbon dioxide output
V˙E  minute ventilation
V˙E/V˙CO2slope  relationship between change in V˙E
and V˙CO2 during incremental exercise
V˙O2  oxygen uptakechedule, but with no inspiratory load. Each week, six praining sessions were performed at home and one training
ession was supervised at the hospital.
ulmonary function. Measurements of forced vital capac-
ty and forced expiratory volume in 1 s were obtained with a
omputerized spirometer (Eric Jaeger, GmbH, Wüerzburg,
ermany) as recommended by the American Thoracic
ociety (12), and results were expressed as percentage of
redicted (13).
Inspiratory muscle function testing was performed using
pressure transducer (MVD-500 V.1.1 Microhard System,
lobalmed, Porto Alegre, Brazil), connected to a system
ith two unidirectional valves (DHD Inspiratory Muscle
rainer, Chicago, Illinois). Maximal static inspiratory pres-
ure was determined in deep inspiration from residual
olume against an occluded airway with a minor air leak (2
m). The highest pressure of six measurements was used
or analysis. The PImax measurement was performed at rest,
nd on the 5th and 10th minute after CPET. Predicted
alues were corrected for age, gender, and weight (14).
dditionally, for the determination of inspiratory muscle
ndurance, an incremental test was used in which patients
reathed continuously through a mouthpiece connected to a
hreshold Inspiratory Muscle Trainer with an initial load of
0% of PImax, and increments of 10% of PImax were added
very 3 min until the patient was unable to continue
reathing. The greatest inspiratory pressure that the subject
as able to sustain for at least 1 min (Pthmax) was taken as
he measure for inspiratory muscle endurance, and was
xpressed as a percentage of maximal inspiratory pressure
Pthmax/PImax). In the second part of the protocol, subjects
reathed against a constant inspiratory submaximal load
quivalent to 80% Pthmax, and the time elapsed to task
ailure was defined as the inspiratory endurance time.
-min walk test. The maximum distance covered during
he walk test was used to assess submaximal functional
apacity (15). Patients self-graded their degree of dyspnea
uring the test using the Borg scale (16).
ardiopulmonary exercise testing. Maximal functional
apacity was evaluated with an incremental exercise test,
ith expired gas analysis, on a treadmill (INBRAMED
0200, Porto Alegre, Brazil), using a ramp protocol, starting
t a speed of 2.4 km·h1 and 2% slope, with 20-s incre-
ents of speed (0.1 to 0.2 km·h1) and 60-s increments in
lope (0.5% to 1.0%), to reach volitional fatigue at approx-
mately 10 min. Twelve-lead electrocardiographic tracings
ere obtained every minute (Nihon Khoden Corp., Tokyo,
apan). Blood pressure was measured every 2 min with a
tandard cuff sphygmomanometer. Metabolic and ventila-
ory variables were measured during and after exercise by
0-s mean aliquots, by a computer-aided gas analyzer (Total
etabolic Analysis System, TEEM 100, Aero Sport, Ann
rbor, Michigan), previously validated (17). Peak oxygen
ptake (V˙O2peak) was considered the highest value of V˙O2
alculated in a period of 20 s of exercise. Maximal circula-
ory power was calculated as the product of V˙O2peak and
eak systolic pressure (18).
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February 21, 2006:757–63 Inspiratory Muscle Training in Heart FailureVentilatory efficiency was estimated using the relation-
hip between minute ventilation (V˙E) and carbon dioxide
utput (V˙CO2), i.e., V˙E/V˙CO2slope, by linear regression
odel using all data points obtained during CPET (3). The
elative amplitudes of oscillations () in V˙E, V˙O2, and V˙CO2
ere calculated for every 20-s period as the ratio between
mplitude and its respective mean throughout the test. The
atio between metabolic (V˙O2, V˙CO2) and ventilatory
scillations (V˙O2/V˙E, V˙CO2/V˙E) were also calculated
19). The V˙O2, V˙CO2, and V˙E kinetics during the first 3 min
f the recovery period were calculated by a linear regression
odel adjusted to a simple exponential curve (V˙O2/t, V˙CO2/
, V˙E/t  slope) (1). The time required for a 50% decrease
rom the V˙O2peak (T1/2V˙O2), V˙CO2peak (T1/2V˙CO2) and V˙E
eak (T1/2V˙E) was calculated using the mathematical model
f the minimum squares through the equation y  ae(kt),
able 1. Baseline Characteristics of Patients Randomized to
-IMT or IMT
Characteristic
P-IMT
Group
(n  16)
IMT
Group
(n  16) p Value*
ender, male/female 10/6 11/5 0.60†
ge, yrs 58  2 54  3 0.21
ody mass index, kg·m2 27  5 27  4 0.86
tiology of heart failure, n
Ischemic 7 6 0.90†
Non-ischemic 9 10 0.60†
jection fraction, % 38  3 39  3 0.79*
orced expiratory volume in
1 s, % predicted
90.1  12.6 83.7  14.5 0.20*
orced vital capacity,
% predicted
84.7  8.8 85.3  13.4 0.96*
Imax, kPa 5.7  0.1 5.9  0.9 0.29*
Imax, % predicted 59.8  2 59.5  2.2 0.89*
˙ O2peak, ml·kg
1·min1 17  0.7 17.2  0.5 0.75*
rugs, %
Diuretics 80 86 0.82†
Digoxin 50 57 0.79†
Angiotensin-converting
enzyme inhibitors
78 85 0.86†
Beta-blocker 50 42 0.10†
alues are expressed as mean standard deviation. *Student t test. †Fisher exact test.
IMT  inspiratory muscle training; P-IMT  placebo-inspiratory muscle
raining; PImaxmaximal static inspiratory pressure; V˙O2peak peak oxygen uptake.
Table 2. Pulmonary Function and Inspiratory
Intervention for Patients Randomized to P-IM
P-IMT
(n  16)
Before
FVC % pred 84.7  8.8 8
FEV1 % pred 90.1  12.6 9
Pthmax, kPa 3.1  0.5
Pthmax/PImax, % 55  14
Endurance time, s 256  132
Values are expressed as mean  standard deviation. Two-w
interaction effects. †p  0.001 for group effect.
FEV1  forced expiratory volume in 1 s; FVC  forced v
static inspiratory pressure; P-IMT  placebo inspiratory muscle tra
1 min during incremental test.here y corresponds to V˙O2, V˙CO2, or V˙E in time, a
orresponds to the slope, k is a constant, and t stands for the
ime.
uality of life. Quality of life was assessed with the
innesota Living With Heart Failure Questionnaire (20).
e analyzed overall scores as well as the separate effects of
hysical and psychological perceptions of quality of life.
tatistical analysis. Data were analyzed on the Statistical
ackage for Social Sciences (version 10.0, SPSS, Chicago,
llinois). Based on the results of previous studies (8), we
stimated that a sample size of 15 individuals in each group
ould have a power of 80% to detect a 10% difference in
eak oxygen uptake, for an   0.05. Descriptive data are
resented as mean  SD. Baseline data were compared by
he Student t test for continuous variables or by the Fisher
xact test for categorical variables. The Pearson correlation
oefficient was used to evaluate associations. The effects of
nterventions on continuous variables were compared by
wo-way analysis of variance for repeated measures
ANOVA), and post-hoc analysis was conducted by the
ukey test. Categorical data were analyzed by the chi-
quare statistic.
ESULTS
atients. Between August 2001 and November 2003,
44 patients with CHF were screened for the study.
inety-six patients did not meet the inclusion or met the
xclusion criteria, and therefore, 44 patients were ran-
omized. For the 22 patients randomized to IMT, 1 had a
yocardial infarction, 1 developed atrial fibrillation, and 4
ere not able complete the training protocol. For the 22
atients allocated to P-IMT, 2 had to be excluded because
f indication of coronary artery bypass graft surgery, 3 for
he development of symptoms at rest, and 1 because of
leeding secondary to oral anticoagulation. Therefore, 16
atients completed the protocol in each group. Table 1
escribes the clinical characteristics for both groups. Etiol-
gy of CHF was predominantly non-ischemic, and patients
ad mild to moderate left ventricular dysfunction as well as
ild to moderate impairment in functional capacity. Pa-
le Function Tests Before and After
IMT
IMT
(n  16)
ter Before After
9.5 85.3  13.4 84.8  15.2
12.6 83.7  14.5 82.4  15.1
0.6 3.2  0.5 3.8  0.5*
15 57  9 66  7*
121 298  154 924  503*†
OVA for repeated measures. *p  0.001 for training and
acity; IMT  inspiratory muscle training; PImax  maximalMusc
T or
Af
3.2 
0.1 
3.2 
56 
246 
ay AN
ital cap
ining; Pthmax  maximal inspiratory pressure sustained for
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Inspiratory Muscle Training in Heart Failure February 21, 2006:757–63ients received similar medications and maintained the same
edical regimen throughout the study period. At one-year
ollow-up, three patients from the IMT group had died and
ve patients from the P-IMT group had died.
ulmonary function and inspiratory muscle function
ests. After 12 weeks, spirometric evaluation did not show
hange in any of the groups (Table 2). The IMT induced
arked improvement in PImax, which was apparent after the
econd week of training and reached an increment of 115%
fter 12 weeks (Fig. 1). Despite the fact that training was
topped after 12 weeks of intervention, patients in the IMT
roup maintained part of the effect one year after starting
he program. Inspiratory muscle endurance, evaluated by the
thmax, Pthmax/PImax, and time sustained in the inspiratory
uscle function test, increased after IMT (Table 2). The
MT resulted in improvement in the recovery of PImax at 10
in after maximal exercise (Fig. 2).
ix-minute walk test. The IMT resulted in a longer dis-
ance covered during the 6-min walk test (IMT, 449 
7 m before and 550  17 m after; P-IMT, 432  41 m
efore and 411  60 m after [ANOVA 0.002 for
roup, training, and interaction effects]). Perception of
yspnea rated by the Borg scale during the 6-min walk
est also improved after IMT (IMT, 3.7  2.0 before and
.5  1.4 after; P-IMT, 3.1  1.3 before and 3.0  1.4
fter [ANOVA 0.002 for group, training, and interac-
ion effects]).
ardiopulmonary exercise testing. Before intervention,
˙ O2peak did not correlate with PImax (r 0.08; p 0.32; n
2). The IMT resulted in improvements in V˙O2peak and V˙E
eak, whereas the peak respiratory exchange ratio (R) was not
hanged by intervention in either group (Table 3). The change
n V˙O2 peak after intervention correlated with the change in
Imax (r  0.62; p  0.001; n  32). Maximal circulatory
igure 1. Weekly values of maximal inspiratory pressure (PImax, mean 
D) for the placebo-inspiratory muscle training group (P-IMT) and for the
nspiratory muscle training group (IMT). After 12 weeks in the program,
ll training was stopped, and 11 patients from each group were re-evaluated
t 48 weeks. *Two-way ANOVA for repeated measures: p  0.01 for
roup, training, and interaction effects. †Significantly (p  0.05) different
rom baseline evaluation by the Tukey test.ower also increased only in the IMT group (Table 3).
t
(Consistent with improvement in ventilatory efficiency,
he V˙E/V˙CO2 slope was reduced after IMT. The relative size
f the oscillations in V˙E (V˙E) was reduced after IMT. The
elative size of the oscillations in V˙O2 (V˙O2) and V˙CO2
V˙CO2) was not changed by either intervention. However,
he ratio between the relative oscillations of V˙E and V˙CO2
ncreased after IMT.
Before the intervention, V˙O2/tslope at the first minute
n the recovery did not correlate with PImax at 5 min after
aximal exercise (r  0.18; p  0.15; n  32). During
ecovery, T1/2 of V˙O2, V˙CO2, and V˙E were faster after IMT
Table 3). Likewise, V˙O2/tslope in the first minute of
ecovery was higher after IMT (Table 3, Fig. 3). The
hange in V˙O2/tslope at the first minute in the recovery
fter intervention correlated with the change PImax at 5 min
fter maximal exercise (r  0.70; p  0.001; n  32).
uality of life. The Minnesota Living With Heart Failure
uestionnaire scores improved after IMT (IMT, 27  4
efore and 6  2 after; P-IMT, 30  13 before and 30 
igure 2. The PImax values (mean  SD) at rest and on the 5th and the
0th min of recovery after maximal cardiopulmonary exercise test. (A)
alues before and (B) after intervention for the placebo inspiratory muscle
raining group (P-IMT) and the inspiratory muscle training group (IMT).
wo-way ANOVA for repeated measurements: §IMT versus P-IMT (p
.01 for group, training, and interaction effects). Multiple comparisons by
he Tukey test: *5th minute versus rest (p 0.05); †10th minute versus rest
p  0.05); ‡10th minute versus 5th min (p  0.05).
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ction effects]). The global improvement was attributed to a
hange in physical dimension from 6  3 to 3  5 because
o changes were observed in the psychological dimension of
he score. Despite the fact that IMT was stopped after 12
eeks of intervention, patients who participated in the IMT
rogram maintained part of the effect on quality of life scores
ne year after starting the program, from 27  8 to 14  3
ANOVA 0.05 for group, training, and interaction effects).
ISCUSSION
n this randomized trial, a home-based, three-month IMT
rogram improved inspiratory muscle strength and endur-
nce as well as quality of life and functional capacity in
atients with CHF and weakness in inspiratory muscles.
oreover, IMT improved peak circulatory power, ventila-
ory efficiency, and oscillations during incremental exercise,
s well as oxygen uptake kinetics during recovery, which are
ll markers of poor prognosis in CHF. The efficacy of IMT
as tested against a similar program with no inspiratory
oad, which served as a placebo intervention, and outcomes
ere blindly evaluated. Interestingly, part of the effect on
Imax and quality of life was sustained after one year, even
hough the patients did not continue training after four
onths. These data provide the first evidence showing that
Table 3. Results Obtained in the Maximal Ca
the IMT Group
P-I
(n 
Before
Peak exercise
V˙E peak, l·min1 47  3
V˙O2 peak, ml·kg
1·min1 17  0.6
V˙CO2 peak, l·min
1 1.3  0.1
R peak 1.0  0.02
Peak circulatory power,
mm Hg·ml O2·kg
2·min1
2,714  505
Ventilatory efficiency
V˙E/V˙CO2 – slope 37  4
Oscillations in gas exchange
V˙E 0.06  0.005
V˙O2 0.01  0.03
V˙CO2 0.06  0.005
V˙O2/V˙E 1.52  0.27
V˙CO2/V˙E 1.02  0.05
Recovery gas exchange
V˙O2/t – slope 1st min
1 0.48  0.12
T1/2V˙O2 (min) 1.55  0.22
T1/2V˙CO2 (min) 1.60  0.3
T1/2V˙E (min) 1.63  0.1
The values are expressed as mean  SD. Two-way ANOV
effects. †p  0.001 for group effect. 1expressed in l · min1
  relative amplitude of oscillations; IMT  inspirato
P-IMT  placebo inspiratory muscle training; R  respirat
slope  kinetics during recovery; VE  minute ventilation;
during incremental exercise; VE/VO2  ventilatory equivalent
uptake; other abbreviations as in Table 1.he effects of IMT are consistent and are partially main- sained after one year of follow-up in patients with CHF and
eakness of inspiratory muscles.
nspiratory muscle strength and endurance. In accor-
ance with previous studies (8–11), IMT did not affect
esting pulmonary function test results but had a major
mpact on all measures of inspiratory muscle strength and
ndurance. The magnitude of improvement in PImax (115%)
n our patients is larger than described in previous studies
8–11), a finding that may be related to the fact that we used
linear pressure resistance device with weekly adjustments
n load, resulting in possible training of other inspiratory
uscles in addition to the diaphragm. Moreover, daily
xercises and the presence of inspiratory muscle weakness in
ll patients may also have contributed to this increment.
he improvement in PImax after maximal exercise is consis-
ent with delayed development in diaphragmatic fatigue (1).
unctional capacity and quality of life. Patients who
articipated in the IMT presented improvement in func-
ional capacity as shown by a 19% increase in 6-min walk
istance, which was also accompanied by a reduction in the
erception of dyspnea. Likewise, there was a 17% increase
n V˙O2peak and a 24% increase in circulatory power,
onsistent with clinically significant improvement in
ardiovascular and respiratory response to maximal exer-
ise. The improvement in functional capacity and the
eduction in perception of dyspnea were probably respon-
ulmonary Exercise Test for the P-IMT and
IMT
(n  16)
After Before After
49  4 48  2.7 62  4*†
17  0.8 17  0.6 21  0.7*†
.3  0.1 1.4  0.4 1.5  0.4*†
.0  0.02 1.0  0.01 1.1  0.02
92  421 2,829  409 3,696  524*†
37  4 35  3.5 30  3*†
06  0.006 0.07  0.005 0.03  0.006*†
01  0.004 0.05  0.035 0.04  0.004
07  0.006 0.07  0.004 0.07  0.006
08  0.37 1.8  0.26 2.12  0.35
1  0.02 1  0.06 1.18  0.02*†
48  0.10 0.48  0.12 0.81  0.27*†
47  0.35 1.56  0.29 1.04  0.16*†
59  0.2 1.60  0.3 1.31  0.2*†
63  0.2 1.62  0.2 1.33  0.2*†
repeated measures. *p  0.001 for training and interaction
1.
scle training; PImax  maximal static inspiratory pressure;
hange ratio; T1/2  time required for 50% from peak; /t –
O2 – slope  relationship between change in V˙E and V˙CO2
ygen uptake; V˙CO2  carbon dioxide output; V˙O2  oxygenrdiop
MT
16)
1
1
2,5
0.
0.
0.
1.
0.
1.
1.
1.
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2-month evaluation, several months after IMT had been
topped.
The IMT can delay the development of diaphragmatic
atigue in patients with CHF, leading to a reduction in the
ecruitment of accessory respiratory muscles, increasing
entilatory efficiency, and/or reducing the blood flow re-
uired by the respiratory muscles during exercise (21). In
HF, there is enhanced ventilatory sensitivity to both
entral and peripheral chemoreceptor stimulation (22), which
an reflexively induce sympathetic vasoconstriction and
educe blood flow to skeletal muscles during exercise.
herefore, diaphragm fatigue may elicit sympathetically
ediated vasoconstriction in limb muscles, a reflex that can
e attenuated by whole-body aerobic exercise training (23).
y improving ventilatory muscle strength and endurance,
MT may also delay the development of fatigue of the
iaphragm, consequently reducing sympathetic activation,
mproving the perfusion of the peripheral muscles, and
ncreasing functional capacity.
entilatory response to exercise. The present study con-
igure 3. Values of the oxygen uptake kinetics during the first 3 min of
ecovery (mean  SD) after maximal cardiopulmonary exercise test before
A) and after (B) intervention for the placebo inspiratory muscle training
roup (P-IMT) and the inspiratory muscle training group (IMT). Overall
wo-way ANOVA for repeated measures: p  0.001 for group, training,
nd interaction effects. *Significantly different between groups (p  0.05)
y the Tukey test.rms that three months of IMT causes substantial improve- fent in the ventilatory efficiency, as shown by a reduction in
he V˙E/V˙CO2slope. Patients with CHF present hyperven-
ilation during exercise, with increased breathing rate and
ecreased tidal volume, resulting in larger pulmonary dead
pace (3). Recent studies have indicated a putative role of an
xaggerated chemoreceptor reflex originating from the ex-
rcising muscle and explaining the hyperventilatory re-
ponse in CHF (23). Indexes reflecting the chemoreceptor
timulation correlate with V˙E/V˙CO2slope and ventilatory
scillations during exercise, variables with prognostic value
n CHF patients (4,24). To our knowledge, this is the first
tudy to show attenuation in ventilatory oscillation during
xercise by IMT. Therefore, improvement in ventilatory
uscle strength and endurance may also attenuate the
xaggerated chemoreflex and improve ventilatory control
uring exercise.
xygen uptake kinetics during recovery. The effects of an
MT program on oxygen kinetics during the recovery from
PET have not been previously studied. Results of the present
tudy show a faster T1/2V˙O2 and an increase in the V˙O2/
slope after IMT. Nanas et al. (1) have shown a relation-
hip between inspiratory muscles weakness 10 min after
aximal CPET and the reduced magnitude or prolonged
˙ O2 recovery time. Therefore, the delay in the recovery of
lood flow to the fatigued diaphragm could contribute to
rolonged kinetics of recovery of V˙O2. In contrast to our
ndings, Myers et al. (25) showed that two months of
igh-intensity whole-body aerobic training improved
˙ O2peak but had no significant effect on V˙O2 kinetics in the
ecovery period in patients with reduced ventricular func-
ion. Therefore, our findings underscore the role of strength
nd endurance of inspiratory muscles as determinants of
xygen uptake kinetics in the recovery period.
tudy limitations. In this small clinical trial, we showed
hat a 12-week program of IMT has a consistent effect on
everal prognostic markers in CHF. However, this study
as designed only to evaluate the efficacy of IMT on
unctional variables and not on survival. Our findings are
imited to patients with mild CHF caused by left ventricular
ystolic dysfunction and weakness in inspiratory muscle, but
recent trial of IMT, including patients with more ad-
anced CHF and with a higher baseline PImax, found similar
esults (11). The training period was maintained for only 12
eeks, which does not allow us to conclude that the effect
n functional capacity and quality of life is long-term.
owever, one-year follow-up showed that the effects on
uality of life are partially maintained. We have suggested
hat part of the beneficial effects of IMT could be mediated
y a reduction in sympathetic vasoconstrictor activity to
eripheral muscle, but no assessment of sympathetic nerve
ctivity was made, and mechanistic studies should be con-
ucted to test this hypothesis.
Because whole-body aerobic exercise training is currently
ndicated for patients with CHF for improvement in func-
ional capacity and possibly for reduction in mortality (26),
t is not known whether the beneficial effects of IMT would
urther improve the functional capacity of patients with
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February 21, 2006:757–63 Inspiratory Muscle Training in Heart FailureHF who perform aerobic exercise regularly. However,
ibarel et al. (27) showed that aerobic exercise training has
o significant effect on the strength of inspiratory muscles,
uggesting that the two programs may result in complemen-
ary effects, a hypothesis that should be addressed by a
ontrolled trial isolating the effects of both interventions.
linical implications. Our findings indicate that a simple
nd inexpensive home-based IMT program results in clin-
cally relevant increments of improvement in submaximal
nd maximal functional capacity, with reduction of percep-
ion of dyspnea and improvement in quality of life. Although
he sample size is not appropriate to assess survival, these
esults, together with the observations of other small trials
8–11), suggest that IMT is a safe intervention that can be
onsidered for the management of patients with CHF,
articularly those with weakness in inspiratory muscles. Our
esults also raise the question of whether routine screening
or weakness of inspiratory muscle should be performed in
atients with CHF.
ONCLUSIONS
his randomized, placebo-controlled trial shows that a
hort-term, home-based program of IMT results in marked
mprovement in inspiratory muscle strength and endurance,
hich results in clinically relevant increments of improve-
ent in submaximal and maximal functional capacity, as
ell as in quality of life in CHF patients with inspiratory
uscle weakness. Moreover, IMT also improves ventilatory
fficiency and oscillations during exercise, peak circulatory
ower, and oxygen uptake kinetics during recovery in this
atient population.
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